US9907953B2 - Fixation sleeve equipped leadless pulse generator - Google Patents
Fixation sleeve equipped leadless pulse generator Download PDFInfo
- Publication number
- US9907953B2 US9907953B2 US14/884,619 US201514884619A US9907953B2 US 9907953 B2 US9907953 B2 US 9907953B2 US 201514884619 A US201514884619 A US 201514884619A US 9907953 B2 US9907953 B2 US 9907953B2
- Authority
- US
- United States
- Prior art keywords
- distal
- sleeve
- pulse generator
- face
- leadless pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000005003 heart tissue Anatomy 0.000 claims abstract description 47
- 230000008859 change Effects 0.000 claims description 5
- 230000007423 decrease Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 11
- 238000002594 fluoroscopy Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 239000007943 implant Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 238000002513 implantation Methods 0.000 description 6
- 239000012212 insulator Substances 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 230000000451 tissue damage Effects 0.000 description 6
- 231100000827 tissue damage Toxicity 0.000 description 6
- 238000001827 electrotherapy Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 210000005242 cardiac chamber Anatomy 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001174 endocardium Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 3
- 239000004944 Liquid Silicone Rubber Substances 0.000 description 2
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007175 bidirectional communication Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006854 communication Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000009791 fibrotic reaction Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 229910000457 iridium oxide Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/057—Anchoring means; Means for fixing the head inside the heart
- A61N1/0573—Anchoring means; Means for fixing the head inside the heart chacterised by means penetrating the heart tissue, e.g. helix needle or hook
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3756—Casings with electrodes thereon, e.g. leadless stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
Definitions
- aspects of the present invention relate to medical apparatus and methods. More specifically, the present disclosure relates to leadless pulse generators equipped with fixation sleeves. The present disclosure also relates to methods of manufacturing and using such leadless pulse generators.
- Leadless pulse generators have a helical anchor at a distal end of the leadless pulse generator.
- the helical anchor is used to secure the leadless pulse generator to cardiac tissue in such a manner that an electrode of the leadless pulse generator is maintained in appropriate tissue contact for cardiac pacing and sensing.
- the leadless pulse generator Since the helical anchor is fixed relative to the rest of the leadless pulse generator, the leadless pulse generator is rotated as a whole relative to the cardiac tissue to cause the helical anchor to screw into the cardiac tissue and thereby fix the leadless pulse generator to the cardiac tissue.
- Implanters make use of a chevron or other shaped radiopaque marker within the body of the device for visual feedback under fluoroscopy when rotating the leadless pulse generator to screw the helical anchor into the cardiac tissue.
- a prescribed number of turns (e.g. 1-1 ⁇ 4 turns) of the leadless pulse generator is recommended for desirable helical anchor fixation in the cardiac tissue.
- verifying that the prescribed number of turns has actually resulted in actual turns of the helical anchor screwing into the cardiac tissue can be a challenge.
- This challenge results from the fact that the leadless pulse generator may be rotated for the prescribed number of turns without the helical anchor fully engaging the cardiac tissue for the entirety of the prescribed number of turns, and the radiopaque marker viewed via fluoroscopy only conveys to the implanter that rotation of the leadless pulse generator is occurring, not that the helical anchor is properly screwing into cardiac tissue.
- the leadless pulse generator includes a body, a helical anchor, an electrode, and a sleeve.
- the body includes a distal end and a proximal end opposite the distal end.
- the helical anchor distally extends from the distal end.
- the electrode is at the distal end.
- the sleeve distally extends from the distal end and includes a proximal face and a distal face opposite the proximal face.
- the proximal face is adjacent the body.
- the sleeve coaxially extends about the helical anchor and further includes a biased state wherein the distal face is near a distal tip of the helical anchor.
- the sleeve is configured to compress such that the distal face displaces proximally towards the proximal face upon the distal face being forced against the cardiac tissue in the course of the helical anchor screwing into the cardiac tissue.
- the sleeve may be radiopaque or include a radiopaque portion or component.
- the leadless pulse generator further includes an anchor mount operably coupled to the distal end and supporting the helical anchor.
- a portion of the sleeve is sandwiched between the anchor mount and the distal end.
- the portion of the sleeve may be a radially inward extending annular ring.
- the electrode may be exposed at a center of the anchor mount, and the anchor mount may be threadably, interference or press fit, swaged, welded, or otherwise operably coupled to the distal end.
- the sleeve includes a proximal section extending distally from the proximal face and a distal section extending proximally from the distal face.
- the sleeve is configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the distal section folds proximally and the distal face increases in diameter.
- the distal section when the sleeve is in the biased state, the distal section includes a conical outer shape and the proximal section includes a cylindrical outer shape.
- the conical outer shape distally increases in diameter.
- the distal face may change from facing distally to facing radially outward when the distal face displaces proximally towards the proximal face.
- the distal section includes a series of longitudinally extending gaps and longitudinally extending members.
- the members distally terminate as part of the distal face.
- the gaps and members are arranged in a uniformly spaced alternating fashion about a circumference of the distal section.
- the members may be wider than the gaps, or the gaps may be wider than the members.
- the members may change from projecting distally to projecting radially outward when the distal face displaces proximally towards the proximal face.
- the sleeve includes a proximal cylindrical section extending distally from the proximal face and a distal bellows section extending proximally from the distal face.
- the distal bellows section includes first and second radially outward projecting circumferentially extending ridges and a radially inward projecting circumferentially extending valley located between the first and second ridges.
- the sleeve is configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the first ridge moves proximally towards the second ridge and the valley decreases in dimension distal-proximal.
- a method of manufacturing a leadless pulse generator includes: positioning a distal electrode of the leadless pulse generator within a hollow interior of a compressible fixation sleeve including at least a radiopaque portion; and coupling the compressible fixation sleeve to the housing of the leadless pulse generator by coupling an anchor mount to the housing such that a portion of the compressible fixation sleeve is sandwiched between the anchor mount and a portion of the housing.
- the sandwiched portion of the compressible fixation sleeve may be in the form of an inner annular ring.
- the housing may include a distal protrusion that boarders the distal electrode and is also positioned in the hollow interior.
- the distal protrusion may mechanically couple with the anchor mount when the anchor mount is coupled to the housing.
- the distal protrusion and the anchor mount may threadably engage with each other in the course of being mechanically coupled with each other.
- FIG. 1 is a diagrammatic depiction of a leadless electrotherapy system electrically coupled to a patient heart as viewed from an anterior side of the patient heart.
- FIG. 2A is a side view of a leadless pulse generator that is generally representative of any of the leadless pulse generators depicted in FIG. 1 .
- FIG. 2B is a distal end view of the leadless pulse generator of FIG. 2A .
- FIG. 2C is a side view of the leadless pulse generator as it appears via fluoroscopy and depicting a chevron-shaped rotation direction indicator that is part of the leadless pulse generator.
- FIG. 3 is a side view of the leadless pulse generator of FIGS. 2 -A- 2 C, except illustrating the leadless pulse generator as being equipped with a compressible radiopaque (or at least partially radiopaque) fixation sleeve.
- FIG. 4A is an enlarged side view of the compressible fixation sleeve employed with the leadless pulse generator of FIG. 3 .
- FIG. 4B is an end view of the compressible fixation sleeve of FIG. 4A .
- FIGS. 5 and 6 are both the same view of the leadless pulse generator depicted in FIG. 3 , except showing the progressive assembly of the sleeve onto the distal end of the leadless pulse generator.
- FIGS. 7A and 7B are, respectively, a side elevation and a cross-sectional elevation of a bellows radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state about an anchor mount and its anchor.
- FIGS. 7C and 7D are, respectively, a side elevation and a cross-sectional elevation of the bellows radiopaque (or at least partially radiopaque) compressible fixation sleeve in a compressed state about the anchor mount and its anchor.
- FIG. 8A is a side elevation of a tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state about an anchor mount and its anchor.
- FIG. 8B is the same view as FIG. 8A , except showing the tubular sleeve in a compressed state about the anchor mount and its anchor.
- FIG. 9A is a side elevation of a slit tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state about an anchor mount and its anchor.
- FIG. 9B is the same view as FIG. 9A , except showing the slit tubular sleeve in a compressed state about the anchor mount and its anchor.
- FIG. 10A is a side elevation of a tined tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state about an anchor mount and its anchor.
- FIG. 10B is the same view as FIG. 10A , except showing the tined tubular sleeve in a compressed state about the anchor mount and its anchor.
- the present disclosure is directed to a leadless pulse generator 120 including a compressible fixation sleeve 130 supported on a distal end of the leadless pulse generator 120 , the sleeve 130 coaxially extending about a helical anchor 66 distally projecting from the distal end of the leadless pulse generator. At least a portion of the sleeve 130 is radiopaque.
- the sleeve 130 is configured to bias distally such that the wall structure of the sleeve circumferentially extends about the anchor 66 to protect the anchor from engagement with cardiovascular tissue in the course of tracking to an implantation site in a patient's heart.
- the sleeve 130 is configured to proximally compress as a distal face 134 of the sleeve 130 abuts against cardiac tissue into which the anchor 66 is being screwed, the distal displacement of the distal face 134 relative to the distal tip of the anchor 66 and/or the proximal face 132 of the sleeve 130 providing information to an implanter via fluoroscopy as to whether or not the anchor 66 is actually screwing into the cardiac tissue of the implant site.
- the sleeve 130 In addition to providing an indication of anchoring of the anchor 66 into cardiac tissue and protecting against inadvertent tissue damage from the anchor while implanting, relocating or retrieving the leadless pulse generator, the sleeve 130 also provides other benefits. Examples of such other benefits include providing resistance against over-rotation of the leadless pulse generator during implant, and a wider contact surface to reduce contact pressure and mitigate tissue damage. Also, the sleeve 130 can form a seal against the endocardium to reduce the possibility of effusion through a potential microperforation created by the anchor 66 extending through the thin myocardium. Finally, the compressible sleeve 130 can act to prevent anti-rotation of an implanted leadless pulse generator 120 .
- Electrotherapy System Employing Leadless Pulse Generator
- FIG. 1 is a diagrammatic depiction of a leadless electrotherapy system 100 electrically coupled to a patient heart 15 as viewed from an anterior side of the patient heart.
- the leadless electrotherapy system 100 employs one or more leadless pulse generators 120 (e.g., leadless pacemaker, leadless implantable cardioverter defibrillator (leadless-ICD), or etc.).
- leadless pulse generators 120 e.g., leadless pacemaker, leadless implantable cardioverter defibrillator (leadless-ICD), or etc.
- each leadless pulse generator 120 is substantially enclosed in a hermetic housing suitable for placement on or attachment to the inside or outside of a cardiac chamber.
- the leadless pulse generator can have two or more electrodes located within, on, or near the housing, for delivering pacing pulses to muscle of the cardiac chamber and optionally for sensing electrical activity from the muscle, and for bidirectional communication with at least one other device within or outside the body.
- the housing can contain a primary battery to provide power for pacing, sensing, and communication, for example bidirectional communication.
- the housing can optionally contain circuits for sensing cardiac activity from the electrodes.
- the housing contains circuits for receiving information from at least one other device via the electrodes and contains circuits for generating pacing pulses for delivery via the electrodes.
- the housing can optionally contain circuits for transmitting information to at least one other device via the electrodes and can optionally contain circuits for monitoring device health.
- the housing contains circuits for controlling these operations in a predetermined manner.
- the housing may contain circuits for receiving and/or transmitting information via other communication means including, for example, Bluetooth, etc.
- a leadless pulse generator 120 can be adapted for implantation into tissue in the human body.
- a leadless cardiac pacemaker can be adapted for implantation adjacent to heart tissue on the inside or outside wall of a cardiac chamber, using two or more electrodes located on or within the housing of the pacemaker, for pacing the cardiac chamber upon receiving a triggering signal from at least one other device within the body.
- Self-contained or leadless pulse generators are typically fixed to an intracardiac implant site by an actively engaging mechanism such as a screw or helical member that screws into the myocardium.
- Examples of such leadless pulse generators are described in the following publications, the disclosures of which are incorporated by reference in their respective entireties herein: (1) U.S. Pat. No. 8,457,742; (2) U.S. Pubiished Application 2007/0088396A1 (now U.S. Pat. No. 9,358,400); (3) U.S. Published Application 2007/0068397A1 (now U.S. Pat. No. 9,216,298); (4) U.S. Pat. No. 8,352,025; (5) U.S. Pat. No. 7,937,148; (6) U.S. Pat. No. 7,945,333; (7) U.S. Pat. No. 8,010,209; and (8) Int'l Publication No. W007047681A2.
- FIGS. 2A and 2B are, respectively, a side view and a distal end view of a leadless pulse generator 120 as manufactured by St. Jude Medical, Inc. as its NANOSTIMTM leadless pacemaker.
- the leadless pulse generator 120 can include a hermetic housing 102 with a proximal electrode 104 at a proximal end of the leadless pulse generator and a distal electrode 112 at a distal end of the leadless pulse generator.
- the distal electrode 112 can be in the form of a distal tip electrode 112 .
- the distal electrode 112 can be in the form of a distal ring electrode.
- the distal electrode 112 can be integrated within a helical fixation anchor 66 solely or combined with a distal tip or ring electrode. The distal electrode 112 and the helical anchor 66 are supported on the housing 102 .
- the proximal electrode 104 can be disposed on the housing 102 in the form of a ring electrode 104 .
- the helical fixation anchor 66 can be in the form of a helically wound wire or other structure capable of screwing into tissue for attaching the housing to tissue, such as heart tissue.
- the helical fixation anchor 66 can be electrically inert in that it does not act as an electrode.
- the anchor 66 can be electrically active wherein the anchor 66 is yet another electrode or acts as an extension of, or part of, the distal electrode 112 .
- the housing can also include an electronics compartment 110 within the housing that contains the electronic components necessary for operation of the pulse generator.
- the hermetic housing 102 can be adapted to be implanted on or in a human heart, and can be cylindrically shaped, rectangular, spherical, or any other appropriate shape, for example.
- the housing 102 can include a conductive, biocompatible, inert, and anodically safe material such as titanium, 316 L stainless steel, or other similar materials.
- the housing can further include an insulator disposed on the conductive material to separate electrodes 104 and 112 .
- the insulator can be an insulative coating on a portion of the housing between the electrodes, and can include materials such as silicone, polyurethane, parylene, or another biocompatible and biostable electrical insulator commonly used for implantable medical devices.
- a single insulator is disposed along the portion of the housing between electrodes 104 and 112 .
- the housing itself can include an insulator instead of a conductor, such as an alumina ceramic or other similar materials, and the electrodes can be disposed upon the housing.
- the leadless pulse generator 120 can include a header assembly to isolate electrode 104 from electrode 112 .
- the header assembly can be made from tecothane or another biocompatible plastic, and can contain a ceramic to metal feedthrough, a glass to metal feedthrough, or other appropriate feedthrough insulator as known in the art.
- the electrodes 104 and 112 can include pace/sense electrodes, or return electrodes.
- a low-polarization coating can be applied to the electrodes, such as platinum, platinum-iridium, iridium, iridium-oxide, titanium-nitride, carbon, or other materials commonly used to reduce polarization effects, for example.
- electrode 112 can be a pace/sense electrode and electrode 104 can be a return electrode.
- the electrode 104 can be a portion of the conductive housing 102 that does not include an insulator.
- the leadless pulse generator 120 can also include a delivery/recovery structure 122 at the extreme proximal end of the leadless pulse generator with which a delivery device (e.g., delivery catheter) can interface in the implantation or removal of the leadless pulse generator.
- a delivery device e.g., delivery catheter
- the leadless pulse generator 120 can include an anchor mount 131 that is threadably, interference or press fit, swaged, welded, or otherwise secured to the distal end of the housing 102 and extends about the distal electrode 112 , which distally protrudes from a distal end of the anchor mount 131 .
- the helical anchor 112 is affixed via mechanical means such as welding, press-fit, or other means to the anchor mount 131 such that the anchor mount being threadably or otherwise secured to the housing 102 results in the anchor 112 being secured to the housing.
- the leadless pulse generator 120 can include a chevron-shaped rotation direction indicator 124 supported on, or within, the leadless pulse generator.
- the chevron 124 is radiopaque, and implanters can use the chevron shaped radiopaque marker 124 for visual feedback under fluoroscopy when rotating the leadless pulse generator to screw the helical anchor into the cardiac tissue.
- Electrode 104 can serve as an indifferent electrode for sensing and pacing.
- the fixation anchor may be coated partially or in full for electrical insulation, and a steroid-eluting matrix may be included on or near the device to minimize fibrotic reaction, as is known in conventional pacing electrode-leads.
- the helical fixation anchor 66 may be fixed or extendable/retractable relative to the distal end of the leadless pulse generator 120 .
- FIG. 3 is a side view of the leadless pulse generator 120 of FIGS. 2 -A- 2 C, except illustrating the leadless pulse generator as being equipped with a compressible radiopaque (or at least partially radiopaque) fixation sleeve 130 that extends distally from the housing 102 or another portion of the leadless pulse generator 120 and circumferentially extends about the helical fixation anchor 66 of the leadless pulse generator.
- the sleeve 130 extends to the distal end of the helical anchor 66 .
- the fixation sleeve is intended to compress axially from its biased distally projecting state and optionally expand radially while the helical anchor 66 within the fixation sleeve 130 screws into cardiac tissue.
- the fixation sleeve 130 is advantageous for a number of reasons. First, the sleeve 130 protects cardiac tissue and traversed vasculature from potential trauma as may be caused by interaction with the helical anchor 66 during implant, explant and re-positioning.
- the fixation sleeve 130 can act as an indicator of tissue engagement. Once the leadless pulse generator 120 begins to rotate and the anchor tip engages tissue, the fixation sleeve 130 will be compressed as the anchor/tissue engagement increases. Implanters will be able to visually compare the distal edge of the radiopaque fixation sleeve 130 with the helical anchor position and/or the distal end of the pacing electrode 112 . Once the radiopaque fixation sleeve 130 is compressed sufficiently such that the distal edge of the sleeve is aligned with the pacing electrode 112 , the implanter can be confident that the fixation is fully engaged and the electrode 112 is in contact with the tissue.
- optional anti-rotation features of the fixation sleeve 130 can prevent anchor dislodgement once the fixation sleeve is compressed. Since fixation sleeve compression also results in radial expansion, tine features at the end of the expanded fixation sleeve 130 can help resist anti-rotation of the leadless pulse generator 120 once helical anchor fixation is achieved.
- the fixation sleeve 130 may act as an effective barrier to the effusion of blood out of the heart and into the pericardial space through that micro-perforation.
- fixation sleeve 130 can be used as a guard against over-rotation and tissue damage.
- Sleeve bonding at the base of the fixation sleeve 130 , as well as radial expansion of the fixation sleeve, can act as a stop against over-rotation of the leadless pulse generator 120 and its potential resulting tissue damage.
- the fixation sleeve 130 compresses the surface area against the tissue will grow, thereby decreasing the contact pressure through increased contact surface area. Additional surface area contact will reduce the likelihood of tissue damage as compared to leadless pulse generators not equipped with the fixation sleeve.
- the sleeve 130 includes a proximal face 132 and a distal face 134 opposite the proximal face.
- An exterior proximal cylindrical section 136 extends distally from the proximal face to an exterior transition 138 to an exterior distal conical section 140 that extends distally from the exterior transition 138 to the distal face 134 , which has a diameter that is greater than a diameter of the proximal face 132 .
- the exterior distal conical section 140 provides the sleeve 130 with a distally flared exterior as compared to the cylindrical exterior of the exterior proximal section 136 .
- the sleeve 130 includes a hollow interior 142 which is defined by a series of internal surfaces including an internal proximally expanding conical section 144 distally extending from the proximal face 132 to an inner annular ring 146 .
- An interior intermediate cylindrical section 148 extends distally from the annular ring 146 to an interior transition 150 .
- An interior distally expanding conical section 152 extends distally from the interior transition 150 to the distal face 134 .
- the annular ring 146 includes a proximal surface 154 , a cylindrical inner surface 156 and a distal surface 158 .
- the proximal and distal surfaces 154 , 158 extend radially inward from the adjacent internal surfaces of the wall structure of the sleeve 130 .
- the conical arrangements of the sleeve 130 depicted in FIGS. 4A and 4B work together to facilitate the sleeve folding back on itself as the helical anchor 66 screws increasingly deeper into cardiac tissue abutting against the distal face 134 of the sleeve 130 .
- FIGS. 4A and 4B is described as having an exterior distal conical section 140 and an interior distal conical section 152
- these two distal conical sections 140 , 152 may be simply cylindrical such that the two distal sections 140 , 152 simply extend from their immediately adjacent proximal sections, the sleeve thereby having and overall cylindrical inner and outer shape over its entirety distal the annular ring 146 .
- the sleeve 130 is made of a low-durometer medical grade polymeric material such as a liquid silicone rubber (LSR) elastomer urethane, expanded polytetrafluoroethylene (EPTFE), or most any biocompatible soft thermoplastic, biocompatible textile, or biocompatible woven composite, wherein any of the aforementioned materials form the sleeve 130 and a radiopaque additive such as platinum, platinum-iridium alloy, tantalum, tungsten, TiO 2 , BaSO 4 , or etc. is added throughout the sleeve.
- LSR liquid silicone rubber
- EPTFE expanded polytetrafluoroethylene
- the radiopaque additive could be restricted to a subsection of the sleeve such as the distal section 140 or extreme distal edge of the sleeve 130 .
- the sleeve may have a radiopaque marker in the form of a ring, beads or ring segments extending along a distal circumference or extreme distal circumferential edge of the sleeve 130 .
- the radiopaque ring, beads or ring segments may be inserts molded into the sleeve, the inserts being in the form of a radiopaque material such as platinum, platinum-iridium alloy, tantalum, tungsten, TiO 2 , BaSO 4 , or etc.
- FIGS. 5 and 6 are both the same view of the leadless pulse generator 120 depicted in FIG. 3 , except showing the progressive assembly of the sleeve onto the distal end of the leadless pulse generator.
- the anchor mount 131 and helical anchor 66 are absent from the distal end of the leadless pulse generator 120 , revealing a threaded distal protrusion 160 of the housing 102 , the protrusion 160 extending circumferentially about the distal electrode 112 .
- the sleeve 130 is coaxially aligned with the longitudinal axis of the leadless pulse generator with the proximal face 132 of the sheath 130 facing the distal end of the leadless pulse generator 130 and the distal face 134 of the sheath 130 facing away from the leadless pulse generator.
- the sleeve 130 is then seated against the distal end of the leadless pulse generator 120 such that the threaded distal protrusion 160 and electrode 112 extend through the hollow interior 142 of the sleeve 130 , the proximal conical surface 144 of the sleeve matingly abutting against a complementary conical surface of the distal end of the housing 102 , the proximal surface 154 of the inner annular ring 146 of the sleeve abutting against a distal face of the distal end of the housing 102 , and the cylindrical inner surface 156 of the annular ring 146 of the sleeve 130 making circumferential surface contact with an outer cylindrical surface of the threaded distal protrusion 160 of the housing 102 .
- the sleeve 130 is then secured in place by the anchor mount 131 being threaded or otherwise secured on the distal protrusion 160 of the housing 102 such that the inner annular ring 146 is sandwiched between a proximal end of the anchor mount and the distal end of the housing 102 .
- the compressible radiopaque (or at least partially radiopaque) fixation sleeve 130 will have configurations different than that depicted in FIGS. 3-6 , but will still employ an inner annular ring 146 that is sandwiched between the anchor mount 131 and the housing 102 for securing the sleeve 130 to the housing 102 .
- the sleeve 130 may have a bellows configuration (see FIGS. 7A-7D ), a tubular configuration (see FIGS. 8A and 8B ), a slit tubular configuration (see FIGS. 9A and 9B ), and a tine configuration (see FIGS. 10A and 10B ).
- FIGS. 7A-7D a bellows configuration
- FIGS. 8A and 8B a tubular configuration
- FIGS. 9A and 9B a slit tubular configuration
- FIGS. 10A and 10B a tine configuration
- FIGS. 7A-7D illustrate the bellows sleeve 130 , wherein FIGS. 7A and 7B are, respectively, a side elevation and a cross-sectional elevation of the bellows radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state (i.e., its biased state) about an anchor mount 131 and its anchor 66 , and FIGS. 7C and 7D are, respectively, the same views, except showing the bellows sleeve 130 in a compressed state about the anchor mount 131 and its anchor 66 .
- FIGS. 7A and 7B are, respectively, a side elevation and a cross-sectional elevation of the bellows radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state (i.e., its biased state) about an anchor mount 131 and its anchor 66
- FIGS. 7C and 7D are, respectively, the same views, except
- the sidewall of the bellows sleeve 130 extends in a serpentine fashion between the proximal face 132 and the distal face 134 of the sleeve 130 .
- the wall structure of the sleeve 130 includes a cylindrical section 170 extending distally from the proximal face 132 to the proximal boundary of a bellows structure 171 of the sleeve 130 .
- the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the bellows sleeve 130 depicted in FIGS. 7A-7D for purposes of securing the bellows sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
- the bellows structure 171 proximally begins with a first arcuate radially outward projecting and circumferentially extending ridge 172 .
- the first ridge 172 transitions into an arcuate radially inward projecting and circumferentially extending valley 174 .
- the valley 174 transitions into a second arcuate radially outward projecting and circumferentially extending ridge 176 that transitions into a distal ringed terminus 178 of the sleeve 130 , the distal edge of the distal ringed terminus 178 of the sleeve 130 forming the distal face 134 of the sleeve 130 .
- the distal ringed terminus 178 may have a circular cross-section.
- the distal ringed terminus 178 may be made of a radiopaque pliable polymer material or be a radiopaque ring imbedded in the pliable polymer material forming the rest of the sleeve 130
- the bellows structure 171 compresses proximal-distal, its first and second ridges 172 , 176 abutting together on account of the valley 174 having collapsed radially inward and proximal-distal.
- the helical anchor 66 is hidden within the circumferential confines of the bellows sleeve 130 when the sleeve 130 is in the non-compressed state depicted in FIGS.
- a distal region of the helical anchor 66 is exposed when the sleeve 130 is in the compressed state depicted in FIGS. 7C and 7D on account of the distal face 134 having been compressed proximally closer to the proximal face 132 .
- FIGS. 8A and 8B illustrate the tubular sleeve 130 , wherein FIG. 8A is a side elevation of a tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state (i.e., its biased state) about an anchor mount 131 and its anchor 66 , and FIG. 8B is the same view, except showing the tubular sleeve 130 in a compressed state about the anchor mount 131 and its anchor 66 .
- FIG. 8A is a side elevation of a tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state (i.e., its biased state) about an anchor mount 131 and its anchor 66
- FIG. 8B is the same view, except showing the tubular sleeve 130 in a compressed state about the anchor mount 131 and its anchor 66 .
- the sidewall of the tubular sleeve 130 extends in a generally tubular or cylindrical fashion moving distally from the proximal face 132 until the wall structure of the sleeve radially flairs outward in a generally conical fashion a distal third of the sleeve 130 distally ending at the distal face 134 of the sleeve 130 .
- the wall structure of the sleeve 130 includes a proximal cylindrical section 170 extending distally from the proximal face 132 to the proximal boundary of a distal conical section 140 of the sleeve 130 .
- the distal conical section 140 distally transitions into a distal ringed terminus 178 of the sleeve 130 .
- the distal edge of the distal ringed terminus 178 of the sleeve 130 forms the distal face 134 of the sleeve 130 .
- the distal ringed terminus 178 may have a circular cross-section.
- the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the tubular sleeve 130 depicted in FIGS. 8A and 8B for purposes of securing the tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
- the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state ( FIG. 8A ) to its deflected state ( FIG. 8B ), the distal section 140 folds proximally and the distal face 134 increases in diameter. Also, the distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132 .
- FIGS. 9A and 9B illustrate the slit tubular sleeve 130
- FIG. 9A is a side elevation of a slit tubular radiopaque (or at least partially radiopaque) compressible fixation sleeve in a non-compressed state (i.e., its biased state) about an anchor mount 131 and its anchor 66
- FIG. 9B is the same view, except showing the slit tubular sleeve 130 in a compressed state about the anchor mount 131 and its anchor 66 .
- the two embodiments are substantially similar, except the distal conical region 140 of the slit tubular embodiment of FIGS. 9A and 9B includes a series of relatively narrow gaps 200 defined in the distal conical section 140 of the slit tubular embodiment of FIGS. 9A and 9B .
- the distal conical section 140 of the slit tubular embodiment of FIGS. 9A and 9B includes a series of relatively narrow gaps 200 defined in the distal conical section 140 of the slit tubular embodiment of FIGS. 9A and 9B .
- 9A and 9B includes a series of longitudinally extending slits or slots 200 extending the length of the distal conical section 140 , and these slits 200 are evenly distributed about the circumference of the distal conical section 140 .
- the slits 200 may be rectangular shaped or any other shape.
- the slits 200 define a series of longitudinally extending readily pliable members 202 that are evenly distributed about the circumference of the distal conical section 140 .
- the members 202 may be rectangular shaped or any other shape.
- the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the slit tubular sleeve 130 depicted in FIGS. 9A and 9B for purposes of securing the slit tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
- the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state ( FIG. 9A ) to its deflected state ( FIG. 9B ), the distal section 140 folds proximally and the distal face 134 increases in diameter.
- distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132
- members 202 change from projecting distally to projecting radially outward when the distal face 134 displaces proximally towards the proximal face 132 .
- the two embodiments are substantially similar, except the slit tubular embodiment of FIGS. 9A and 9B includes a series of relatively narrow gaps 200 and a series of relatively wide members 202 while the tined tubular embodiment includes a series of relatively wide gaps 200 and a series of relatively narrow pliable members 202 that may be considered pliable tines 202 .
- 10A and 10B includes a series of longitudinally extending slits or slots 200 extending the length of the distal conical section 140 , and these slits 200 are evenly distributed about the circumference of the distal conical section 140 .
- the slits 200 may be rectangular shaped or any other shape.
- the slits 200 define a series of longitudinally extending readily pliable members or tines 202 that are evenly distributed about the circumference of the distal conical section 140 .
- the members 202 may be rectangular shaped or any other shape.
- the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the tined tubular sleeve 130 depicted in FIGS. 10A and 10B for purposes of securing the tined tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
- the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state ( FIG. 10A ) to its deflected state ( FIG. 10B ), the distal section 140 folds proximally and the distal face 134 increases in diameter. Also, the distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132 . Further, the members 202 change from projecting distally to projecting radially outward when the distal face 134 displaces proximally towards the proximal face 132 .
- the following discussion pertains to a delivery method for implanting a leadless pulse generator 120 equipped with a fixation sleeve 130 such as any of those disclosed herein.
- the method begins with the leadless pulse generator 120 being tracked via delivery tools (e.g., a delivery catheter, etc.) through the patient vasculature to an implantation site in the patient's heart.
- delivery tools e.g., a delivery catheter, etc.
- gentle forward pressure is applied on the delivery catheter until noticing a slight movement of the delivery catheter proximal to the leadless pulse generator and synchronous to the heartbeat.
- the curve of the catheter down to the inferior vena cava is visualized via fluoroscopy.
- the implant site and the distal region of the delivery tool(s), plus the leadless pulse generator 120 and its fixation sleeve 130 , are visualized via fluoroscopy while the leadless pulse generator 120 is caused to rotate clockwise as the radiopaque marker 124 of the leadless pulse generator is observed, its turns being counted for the appropriate number of turns to cause the helical anchor 66 to screw fully into the cardiac tissue.
- the distal face 134 of the radiopaque fixation sleeve 130 and the helical anchor 66 are observed via fluoroscopy, including the positional relationship of the distal face 134 of the sleeve 130 relative to the anchor 66 .
- the implanter can safely continue rotating the leadless pulse generator until alignment is observed.
- the implanter can uncouple the leadless pulse generator 120 from the delivery tool(s) with confidence that the leadless pulse generator 120 is securely anchored to the engaged cardiac tissue.
- the fixation sleeve equipped leadless pulse generator 120 disclosed herein is advantageous for a number of reasons.
- the protective sleeve 130 prevents helical anchor engagement or deformation due to inadvertent snagging of cardiac tissue.
- the compressible sleeve 130 allows fluoroscopic evaluation of distance between cardiac tissue and the distal end electrode 112 , thereby conveying information to the implanter regarding whether or not the anchor 66 is properly screwing into cardiac tissue and to what extent.
- the compressible sleeve 130 provides resistance against over-rotation of the leadless pulse generator during implant.
- the compressible sleeve 130 provides additional contact surface area to reduce contact pressure and mitigate tissue damage.
- the compressible sleeve forms a seal against the endocardium to reduce the possibility of effusion through any potential microperforation created by the helical anchor 66 extending through the thin myocardium.
- the compressible sleeve 130 with tines or other radially splaying members 202 can act to prevent anti-rotation of an implanted leadless pulse generator 120 .
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Electrotherapy Devices (AREA)
- Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
Abstract
A leadless pulse generator is disclosed herein. The leadless pulse generator has a body, a helical anchor, an electrode, and a sleeve. The body includes a distal end and a proximal end opposite the distal end. The helical anchor distally extends from the distal end. The electrode is at the distal end. The sleeve distally extends from the distal end and has a proximal face and a distal face opposite the proximal face. The proximal face is adjacent the body. The sleeve coaxially extends about the helical anchor and further has a biased state wherein the distal face is near a distal tip of the helical anchor. The sleeve is configured to compress such that the distal face displaces proximally towards the proximal face upon the distal face being forced against the cardiac tissue in the course of the helical anchor screwing into the cardiac tissue.
Description
Aspects of the present invention relate to medical apparatus and methods. More specifically, the present disclosure relates to leadless pulse generators equipped with fixation sleeves. The present disclosure also relates to methods of manufacturing and using such leadless pulse generators.
Leadless pulse generators have a helical anchor at a distal end of the leadless pulse generator. The helical anchor is used to secure the leadless pulse generator to cardiac tissue in such a manner that an electrode of the leadless pulse generator is maintained in appropriate tissue contact for cardiac pacing and sensing.
Since the helical anchor is fixed relative to the rest of the leadless pulse generator, the leadless pulse generator is rotated as a whole relative to the cardiac tissue to cause the helical anchor to screw into the cardiac tissue and thereby fix the leadless pulse generator to the cardiac tissue. Implanters make use of a chevron or other shaped radiopaque marker within the body of the device for visual feedback under fluoroscopy when rotating the leadless pulse generator to screw the helical anchor into the cardiac tissue.
A prescribed number of turns (e.g. 1-¼ turns) of the leadless pulse generator is recommended for desirable helical anchor fixation in the cardiac tissue. However, verifying that the prescribed number of turns has actually resulted in actual turns of the helical anchor screwing into the cardiac tissue can be a challenge. This challenge results from the fact that the leadless pulse generator may be rotated for the prescribed number of turns without the helical anchor fully engaging the cardiac tissue for the entirety of the prescribed number of turns, and the radiopaque marker viewed via fluoroscopy only conveys to the implanter that rotation of the leadless pulse generator is occurring, not that the helical anchor is properly screwing into cardiac tissue.
Consequently, there is a need in the art for an improved leadless pulse generator configuration and related methods of manufacture and use.
A leadless pulse generator for administering therapy to cardiac tissue is disclosed herein. In one embodiment, the leadless pulse generator includes a body, a helical anchor, an electrode, and a sleeve. The body includes a distal end and a proximal end opposite the distal end. The helical anchor distally extends from the distal end. The electrode is at the distal end. The sleeve distally extends from the distal end and includes a proximal face and a distal face opposite the proximal face. The proximal face is adjacent the body. The sleeve coaxially extends about the helical anchor and further includes a biased state wherein the distal face is near a distal tip of the helical anchor. The sleeve is configured to compress such that the distal face displaces proximally towards the proximal face upon the distal face being forced against the cardiac tissue in the course of the helical anchor screwing into the cardiac tissue. The sleeve may be radiopaque or include a radiopaque portion or component.
In one embodiment, the leadless pulse generator further includes an anchor mount operably coupled to the distal end and supporting the helical anchor. A portion of the sleeve is sandwiched between the anchor mount and the distal end. The portion of the sleeve may be a radially inward extending annular ring. The electrode may be exposed at a center of the anchor mount, and the anchor mount may be threadably, interference or press fit, swaged, welded, or otherwise operably coupled to the distal end.
In one embodiment, the sleeve includes a proximal section extending distally from the proximal face and a distal section extending proximally from the distal face. The sleeve is configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the distal section folds proximally and the distal face increases in diameter.
In one embodiment, when the sleeve is in the biased state, the distal section includes a conical outer shape and the proximal section includes a cylindrical outer shape. The conical outer shape distally increases in diameter. The distal face may change from facing distally to facing radially outward when the distal face displaces proximally towards the proximal face.
In one embodiment, the distal section includes a series of longitudinally extending gaps and longitudinally extending members. The members distally terminate as part of the distal face. The gaps and members are arranged in a uniformly spaced alternating fashion about a circumference of the distal section. The members may be wider than the gaps, or the gaps may be wider than the members. The members may change from projecting distally to projecting radially outward when the distal face displaces proximally towards the proximal face.
In one embodiment, the sleeve includes a proximal cylindrical section extending distally from the proximal face and a distal bellows section extending proximally from the distal face. The distal bellows section includes first and second radially outward projecting circumferentially extending ridges and a radially inward projecting circumferentially extending valley located between the first and second ridges. The sleeve is configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the first ridge moves proximally towards the second ridge and the valley decreases in dimension distal-proximal.
A method of manufacturing a leadless pulse generator is also disclosed herein. In one embodiment, the method includes: positioning a distal electrode of the leadless pulse generator within a hollow interior of a compressible fixation sleeve including at least a radiopaque portion; and coupling the compressible fixation sleeve to the housing of the leadless pulse generator by coupling an anchor mount to the housing such that a portion of the compressible fixation sleeve is sandwiched between the anchor mount and a portion of the housing.
The sandwiched portion of the compressible fixation sleeve may be in the form of an inner annular ring. The housing may include a distal protrusion that boarders the distal electrode and is also positioned in the hollow interior. The distal protrusion may mechanically couple with the anchor mount when the anchor mount is coupled to the housing. For example, the distal protrusion and the anchor mount may threadably engage with each other in the course of being mechanically coupled with each other.
While multiple embodiments are disclosed, still other embodiments of the present disclosure will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the disclosure. As will be realized, the invention is capable of modifications in various aspects, all without departing from the spirit and scope of the present disclosure. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
The description will be more fully understood with reference to the following figures, which are presented as various embodiments of the disclosure and should not be construed as a complete recitation of the scope of the disclosure, wherein:
The present disclosure is directed to a leadless pulse generator 120 including a compressible fixation sleeve 130 supported on a distal end of the leadless pulse generator 120, the sleeve 130 coaxially extending about a helical anchor 66 distally projecting from the distal end of the leadless pulse generator. At least a portion of the sleeve 130 is radiopaque. The sleeve 130 is configured to bias distally such that the wall structure of the sleeve circumferentially extends about the anchor 66 to protect the anchor from engagement with cardiovascular tissue in the course of tracking to an implantation site in a patient's heart. The sleeve 130 is configured to proximally compress as a distal face 134 of the sleeve 130 abuts against cardiac tissue into which the anchor 66 is being screwed, the distal displacement of the distal face 134 relative to the distal tip of the anchor 66 and/or the proximal face 132 of the sleeve 130 providing information to an implanter via fluoroscopy as to whether or not the anchor 66 is actually screwing into the cardiac tissue of the implant site.
In addition to providing an indication of anchoring of the anchor 66 into cardiac tissue and protecting against inadvertent tissue damage from the anchor while implanting, relocating or retrieving the leadless pulse generator, the sleeve 130 also provides other benefits. Examples of such other benefits include providing resistance against over-rotation of the leadless pulse generator during implant, and a wider contact surface to reduce contact pressure and mitigate tissue damage. Also, the sleeve 130 can form a seal against the endocardium to reduce the possibility of effusion through a potential microperforation created by the anchor 66 extending through the thin myocardium. Finally, the compressible sleeve 130 can act to prevent anti-rotation of an implanted leadless pulse generator 120.
Before beginning a discussion regarding the details of the fixation sleeves 130 disclosed herein, a general discussion will first be given regarding electrotherapy systems employing leadless pulse generators 120.
a. Electrotherapy System Employing Leadless Pulse Generator
In some embodiments, a leadless pulse generator 120 can be adapted for implantation into tissue in the human body. In a particular embodiment, a leadless cardiac pacemaker can be adapted for implantation adjacent to heart tissue on the inside or outside wall of a cardiac chamber, using two or more electrodes located on or within the housing of the pacemaker, for pacing the cardiac chamber upon receiving a triggering signal from at least one other device within the body.
Self-contained or leadless pulse generators are typically fixed to an intracardiac implant site by an actively engaging mechanism such as a screw or helical member that screws into the myocardium. Examples of such leadless pulse generators are described in the following publications, the disclosures of which are incorporated by reference in their respective entireties herein: (1) U.S. Pat. No. 8,457,742; (2) U.S. Pubiished Application 2007/0088396A1 (now U.S. Pat. No. 9,358,400); (3) U.S. Published Application 2007/0068397A1 (now U.S. Pat. No. 9,216,298); (4) U.S. Pat. No. 8,352,025; (5) U.S. Pat. No. 7,937,148; (6) U.S. Pat. No. 7,945,333; (7) U.S. Pat. No. 8,010,209; and (8) Int'l Publication No. W007047681A2.
To begin a more detailed discussion of the features of a leadless pulse generator, reference is made to FIGS. 2A and 2B , which are, respectively, a side view and a distal end view of a leadless pulse generator 120 as manufactured by St. Jude Medical, Inc. as its NANOSTIM™ leadless pacemaker. As can be understood from FIGS. 2A and 2B , the leadless pulse generator 120 can include a hermetic housing 102 with a proximal electrode 104 at a proximal end of the leadless pulse generator and a distal electrode 112 at a distal end of the leadless pulse generator.
As shown in FIGS. 2A and 2B , the distal electrode 112 can be in the form of a distal tip electrode 112. In other embodiments, the distal electrode 112 can be in the form of a distal ring electrode. In some embodiments, the distal electrode 112 can be integrated within a helical fixation anchor 66 solely or combined with a distal tip or ring electrode. The distal electrode 112 and the helical anchor 66 are supported on the housing 102.
The proximal electrode 104 can be disposed on the housing 102 in the form of a ring electrode 104. The helical fixation anchor 66 can be in the form of a helically wound wire or other structure capable of screwing into tissue for attaching the housing to tissue, such as heart tissue. The helical fixation anchor 66 can be electrically inert in that it does not act as an electrode. Alternatively, the anchor 66 can be electrically active wherein the anchor 66 is yet another electrode or acts as an extension of, or part of, the distal electrode 112.
The housing can also include an electronics compartment 110 within the housing that contains the electronic components necessary for operation of the pulse generator. The hermetic housing 102 can be adapted to be implanted on or in a human heart, and can be cylindrically shaped, rectangular, spherical, or any other appropriate shape, for example.
The housing 102 can include a conductive, biocompatible, inert, and anodically safe material such as titanium, 316L stainless steel, or other similar materials. The housing can further include an insulator disposed on the conductive material to separate electrodes 104 and 112. The insulator can be an insulative coating on a portion of the housing between the electrodes, and can include materials such as silicone, polyurethane, parylene, or another biocompatible and biostable electrical insulator commonly used for implantable medical devices. In one embodiment, a single insulator is disposed along the portion of the housing between electrodes 104 and 112. In some embodiments, the housing itself can include an insulator instead of a conductor, such as an alumina ceramic or other similar materials, and the electrodes can be disposed upon the housing.
In one embodiment, the leadless pulse generator 120 can include a header assembly to isolate electrode 104 from electrode 112. The header assembly can be made from tecothane or another biocompatible plastic, and can contain a ceramic to metal feedthrough, a glass to metal feedthrough, or other appropriate feedthrough insulator as known in the art.
The electrodes 104 and 112 can include pace/sense electrodes, or return electrodes. A low-polarization coating can be applied to the electrodes, such as platinum, platinum-iridium, iridium, iridium-oxide, titanium-nitride, carbon, or other materials commonly used to reduce polarization effects, for example. In FIG. 2A , electrode 112 can be a pace/sense electrode and electrode 104 can be a return electrode. The electrode 104 can be a portion of the conductive housing 102 that does not include an insulator.
As can be understood from FIG. 2A , the leadless pulse generator 120 can also include a delivery/recovery structure 122 at the extreme proximal end of the leadless pulse generator with which a delivery device (e.g., delivery catheter) can interface in the implantation or removal of the leadless pulse generator.
As illustrated in FIGS. 2A and 2B , the leadless pulse generator 120 can include an anchor mount 131 that is threadably, interference or press fit, swaged, welded, or otherwise secured to the distal end of the housing 102 and extends about the distal electrode 112, which distally protrudes from a distal end of the anchor mount 131. The helical anchor 112 is affixed via mechanical means such as welding, press-fit, or other means to the anchor mount 131 such that the anchor mount being threadably or otherwise secured to the housing 102 results in the anchor 112 being secured to the housing.
As can be understood from FIG. 2C , which is a side view of the leadless pulse generator as it appears via fluoroscopy, the leadless pulse generator 120 can include a chevron-shaped rotation direction indicator 124 supported on, or within, the leadless pulse generator. The chevron 124 is radiopaque, and implanters can use the chevron shaped radiopaque marker 124 for visual feedback under fluoroscopy when rotating the leadless pulse generator to screw the helical anchor into the cardiac tissue.
Several techniques and structures can be used for attaching the housing 102 to the interior or exterior wall of the heart as depicted in FIG. 1 . The leadless pulse generator can be delivered endocardially or epicardially through a guiding catheter. A torqueable catheter can be used to rotate the housing and force the helical fixation anchor 66 into heart tissue, thus affixing the fixation anchor (and also the distal electrode in FIG. 2A ) into contact with stimulatable tissue, as illustrated in FIG. 1 . Electrode 104 can serve as an indifferent electrode for sensing and pacing. The fixation anchor may be coated partially or in full for electrical insulation, and a steroid-eluting matrix may be included on or near the device to minimize fibrotic reaction, as is known in conventional pacing electrode-leads. The helical fixation anchor 66 may be fixed or extendable/retractable relative to the distal end of the leadless pulse generator 120.
b. Compressible Radiopaque Fixation Sleeve Distally Extending From Leadless Pulse Generator Housing And Circumferentially Extending About Helical Fixation Anchor
The fixation sleeve 130 is advantageous for a number of reasons. First, the sleeve 130 protects cardiac tissue and traversed vasculature from potential trauma as may be caused by interaction with the helical anchor 66 during implant, explant and re-positioning.
Second, the fixation sleeve 130 can act as an indicator of tissue engagement. Once the leadless pulse generator 120 begins to rotate and the anchor tip engages tissue, the fixation sleeve 130 will be compressed as the anchor/tissue engagement increases. Implanters will be able to visually compare the distal edge of the radiopaque fixation sleeve 130 with the helical anchor position and/or the distal end of the pacing electrode 112. Once the radiopaque fixation sleeve 130 is compressed sufficiently such that the distal edge of the sleeve is aligned with the pacing electrode 112, the implanter can be confident that the fixation is fully engaged and the electrode 112 is in contact with the tissue.
Third and as discussed in detail below, optional anti-rotation features of the fixation sleeve 130 can prevent anchor dislodgement once the fixation sleeve is compressed. Since fixation sleeve compression also results in radial expansion, tine features at the end of the expanded fixation sleeve 130 can help resist anti-rotation of the leadless pulse generator 120 once helical anchor fixation is achieved.
Fourth, if the helical anchor 66 inadvertently pierces transmurally through a very thin region of the atrial or ventricular wall, the fixation sleeve 130 may act as an effective barrier to the effusion of blood out of the heart and into the pericardial space through that micro-perforation.
Finally, the fixation sleeve 130 can be used as a guard against over-rotation and tissue damage. Sleeve bonding at the base of the fixation sleeve 130, as well as radial expansion of the fixation sleeve, can act as a stop against over-rotation of the leadless pulse generator 120 and its potential resulting tissue damage. As the fixation sleeve 130 compresses, the surface area against the tissue will grow, thereby decreasing the contact pressure through increased contact surface area. Additional surface area contact will reduce the likelihood of tissue damage as compared to leadless pulse generators not equipped with the fixation sleeve.
As can be understood from FIGS. 4A and 4B , which are, respectively, enlarged side and end views of the fixation sleeve 130 employed with the leadless pulse generator 120 of FIG. 3 , the sleeve 130 includes a proximal face 132 and a distal face 134 opposite the proximal face. An exterior proximal cylindrical section 136 extends distally from the proximal face to an exterior transition 138 to an exterior distal conical section 140 that extends distally from the exterior transition 138 to the distal face 134, which has a diameter that is greater than a diameter of the proximal face 132. Thus, the exterior distal conical section 140 provides the sleeve 130 with a distally flared exterior as compared to the cylindrical exterior of the exterior proximal section 136.
The sleeve 130 includes a hollow interior 142 which is defined by a series of internal surfaces including an internal proximally expanding conical section 144 distally extending from the proximal face 132 to an inner annular ring 146. An interior intermediate cylindrical section 148 extends distally from the annular ring 146 to an interior transition 150. An interior distally expanding conical section 152 extends distally from the interior transition 150 to the distal face 134. The annular ring 146 includes a proximal surface 154, a cylindrical inner surface 156 and a distal surface 158. The proximal and distal surfaces 154, 158 extend radially inward from the adjacent internal surfaces of the wall structure of the sleeve 130. The conical arrangements of the sleeve 130 depicted in FIGS. 4A and 4B work together to facilitate the sleeve folding back on itself as the helical anchor 66 screws increasingly deeper into cardiac tissue abutting against the distal face 134 of the sleeve 130.
While the embodiment depicted in FIGS. 4A and 4B is described as having an exterior distal conical section 140 and an interior distal conical section 152, in other embodiments, these two distal conical sections 140, 152 may be simply cylindrical such that the two distal sections 140, 152 simply extend from their immediately adjacent proximal sections, the sleeve thereby having and overall cylindrical inner and outer shape over its entirety distal the annular ring 146.
In one embodiment, the sleeve 130 is made of a low-durometer medical grade polymeric material such as a liquid silicone rubber (LSR) elastomer urethane, expanded polytetrafluoroethylene (EPTFE), or most any biocompatible soft thermoplastic, biocompatible textile, or biocompatible woven composite, wherein any of the aforementioned materials form the sleeve 130 and a radiopaque additive such as platinum, platinum-iridium alloy, tantalum, tungsten, TiO2, BaSO4, or etc. is added throughout the sleeve. Alternatively, in one embodiment, the radiopaque additive could be restricted to a subsection of the sleeve such as the distal section 140 or extreme distal edge of the sleeve 130. In one embodiment, the sleeve may have a radiopaque marker in the form of a ring, beads or ring segments extending along a distal circumference or extreme distal circumferential edge of the sleeve 130. In such an embodiment, the radiopaque ring, beads or ring segments may be inserts molded into the sleeve, the inserts being in the form of a radiopaque material such as platinum, platinum-iridium alloy, tantalum, tungsten, TiO2, BaSO4, or etc.
To discuss the assembly of the sleeve 130 onto the distal end of the leadless pulse generator 120, reference is made to FIGS. 5 and 6 , which are both the same view of the leadless pulse generator 120 depicted in FIG. 3 , except showing the progressive assembly of the sleeve onto the distal end of the leadless pulse generator. As shown in FIG. 5 , the anchor mount 131 and helical anchor 66 are absent from the distal end of the leadless pulse generator 120, revealing a threaded distal protrusion 160 of the housing 102, the protrusion 160 extending circumferentially about the distal electrode 112. To begin the assembly, the sleeve 130 is coaxially aligned with the longitudinal axis of the leadless pulse generator with the proximal face 132 of the sheath 130 facing the distal end of the leadless pulse generator 130 and the distal face 134 of the sheath 130 facing away from the leadless pulse generator.
As shown in FIG. 6 and with reference to FIGS. 4A, 4B and 5 , the sleeve 130 is then seated against the distal end of the leadless pulse generator 120 such that the threaded distal protrusion 160 and electrode 112 extend through the hollow interior 142 of the sleeve 130, the proximal conical surface 144 of the sleeve matingly abutting against a complementary conical surface of the distal end of the housing 102, the proximal surface 154 of the inner annular ring 146 of the sleeve abutting against a distal face of the distal end of the housing 102, and the cylindrical inner surface 156 of the annular ring 146 of the sleeve 130 making circumferential surface contact with an outer cylindrical surface of the threaded distal protrusion 160 of the housing 102.
As depicted in FIG. 3 and with reference to FIGS. 4A-6 , the sleeve 130 is then secured in place by the anchor mount 131 being threaded or otherwise secured on the distal protrusion 160 of the housing 102 such that the inner annular ring 146 is sandwiched between a proximal end of the anchor mount and the distal end of the housing 102.
In some embodiments, the compressible radiopaque (or at least partially radiopaque) fixation sleeve 130 will have configurations different than that depicted in FIGS. 3-6 , but will still employ an inner annular ring 146 that is sandwiched between the anchor mount 131 and the housing 102 for securing the sleeve 130 to the housing 102. For example and as discussed in detail below, the sleeve 130 may have a bellows configuration (see FIGS. 7A-7D ), a tubular configuration (see FIGS. 8A and 8B ), a slit tubular configuration (see FIGS. 9A and 9B ), and a tine configuration (see FIGS. 10A and 10B ). Each of the configurations will now be discussed in turn.
Referring to FIGS. 7A and 7B and continuing proximal to distal along the bellows structure 171 from the cylindrical section 170, the bellows structure 171 proximally begins with a first arcuate radially outward projecting and circumferentially extending ridge 172. The first ridge 172 transitions into an arcuate radially inward projecting and circumferentially extending valley 174. The valley 174 transitions into a second arcuate radially outward projecting and circumferentially extending ridge 176 that transitions into a distal ringed terminus 178 of the sleeve 130, the distal edge of the distal ringed terminus 178 of the sleeve 130 forming the distal face 134 of the sleeve 130. The distal ringed terminus 178 may have a circular cross-section. In one embodiment, the distal ringed terminus 178 may be made of a radiopaque pliable polymer material or be a radiopaque ring imbedded in the pliable polymer material forming the rest of the sleeve 130
When the bellows sleeve 130 is compressed from the non-compressed state of FIGS. 7A and 7B to the compressed state of FIGS. 7C and 7D , the bellows structure 171 compresses proximal-distal, its first and second ridges 172, 176 abutting together on account of the valley 174 having collapsed radially inward and proximal-distal. Thus, while the helical anchor 66 is hidden within the circumferential confines of the bellows sleeve 130 when the sleeve 130 is in the non-compressed state depicted in FIGS. 7A and 7B , a distal region of the helical anchor 66 is exposed when the sleeve 130 is in the compressed state depicted in FIGS. 7C and 7D on account of the distal face 134 having been compressed proximally closer to the proximal face 132.
Although not illustrated in FIGS. 8A and 8B , in one embodiment, the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the tubular sleeve 130 depicted in FIGS. 8A and 8B for purposes of securing the tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
When the tubular sleeve 130 is compressed from the non-compressed state of FIG. 8A to the compressed state of FIG. 8B , the distal conical section 140 proximally folds back on itself and radially outwardly expands in diameter. Thus, while the helical anchor 66 is hidden within the circumferential confines of the tubular sleeve 130 when the sleeve 130 is in the non-compressed state depicted in FIG. 8A , a distal region of the helical anchor 66 is exposed when the sleeve 130 is in the compressed state depicted in FIG. 8B on account of the distal face 134 having been compressed proximally closer to the proximal face 132.
As can be understood from a comparison of FIGS. 8A and 8B , the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state (FIG. 8A ) to its deflected state (FIG. 8B ), the distal section 140 folds proximally and the distal face 134 increases in diameter. Also, the distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132.
As can be understood from a comparison of the tubular embodiment depicted in FIGS. 8A and 8B to the slit tubular embodiment of FIGS. 9A and 9B , the two embodiments are substantially similar, except the distal conical region 140 of the slit tubular embodiment of FIGS. 9A and 9B includes a series of relatively narrow gaps 200 defined in the distal conical section 140 of the slit tubular embodiment of FIGS. 9A and 9B . Specifically, the distal conical section 140 of the slit tubular embodiment of FIGS. 9A and 9B includes a series of longitudinally extending slits or slots 200 extending the length of the distal conical section 140, and these slits 200 are evenly distributed about the circumference of the distal conical section 140. The slits 200 may be rectangular shaped or any other shape. The slits 200 define a series of longitudinally extending readily pliable members 202 that are evenly distributed about the circumference of the distal conical section 140. The members 202 may be rectangular shaped or any other shape.
Although not illustrated in FIGS. 9A and 9B , in one embodiment, the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the slit tubular sleeve 130 depicted in FIGS. 9A and 9B for purposes of securing the slit tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
When the slit tubular sleeve 130 is compressed from the non-compressed state of FIG. 9A to the compressed state of FIG. 9B , the members 202 of the distal conical section 140 proximally fold back on themselves and radially outwardly splay in an increased diameter. Thus, while the helical anchor 66 is hidden within the circumferential confines of the slit tubular sleeve 130 when the sleeve 130 is in the non-compressed state depicted in FIG. 9A , a distal region of the helical anchor 66 is exposed when the sleeve 130 is in the compressed state depicted in FIG. 9B on account of the distal face 134 having been compressed proximally closer to the proximal face 132.
As can be understood from a comparison of FIGS. 9A and 9B , the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state (FIG. 9A ) to its deflected state (FIG. 9B ), the distal section 140 folds proximally and the distal face 134 increases in diameter. Also, the distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132, Further, the members 202 change from projecting distally to projecting radially outward when the distal face 134 displaces proximally towards the proximal face 132.
As can be understood from a comparison of the slit tubular embodiment depicted in FIGS. 9A and 9B to the tined tubular embodiment of FIGS. 10A and 10B , the two embodiments are substantially similar, except the slit tubular embodiment of FIGS. 9A and 9B includes a series of relatively narrow gaps 200 and a series of relatively wide members 202 while the tined tubular embodiment includes a series of relatively wide gaps 200 and a series of relatively narrow pliable members 202 that may be considered pliable tines 202. Specifically, the distal conical section 140 of the tined tubular embodiment of FIGS. 10A and 10B includes a series of longitudinally extending slits or slots 200 extending the length of the distal conical section 140, and these slits 200 are evenly distributed about the circumference of the distal conical section 140. The slits 200 may be rectangular shaped or any other shape. The slits 200 define a series of longitudinally extending readily pliable members or tines 202 that are evenly distributed about the circumference of the distal conical section 140. The members 202 may be rectangular shaped or any other shape.
Although not illustrated in FIGS. 10A and 10B , in one embodiment, the inner annular ring 146 discussed above with respect to FIGS. 4A and 4B may be similarly locate in the cylindrical section 170 of the tined tubular sleeve 130 depicted in FIGS. 10A and 10B for purposes of securing the tined tubular sleeve 130 to the housing 102 of the leadless pulse generator in a manner as discussed with respect to FIGS. 3-6 above.
When the tined tubular sleeve 130 is compressed from the non-compressed state (i.e., its biased state) of FIG. 10A to the compressed state of FIG. 10B , the members or tines 202 of the distal conical section 140 proximally fold back on themselves and radially outwardly splay in an increased diameter. Thus, while the helical anchor 66 is hidden within the circumferential confines of the tined tubular sleeve 130 when the sleeve 130 is in the non-compressed state depicted in FIG. 10A , a distal region of the helical anchor 66 is exposed when the sleeve 130 is in the compressed state depicted in FIG. 10B on account of the distal face 134 having been compressed proximally closer to the proximal face 132.
As can be understood from a comparison of FIGS. 10A and 10B , the sleeve 130 is configured such that, in the course of the helical anchor 66 screwing into the cardiac tissue and the distal face 134 being forced against the cardiac tissue, thereby transitioning the sleeve 130 from its biased state (FIG. 10A ) to its deflected state (FIG. 10B ), the distal section 140 folds proximally and the distal face 134 increases in diameter. Also, the distal face 134 changes from facing distally to facing radially outward when the distal face 134 displaces proximally towards the proximal face 132. Further, the members 202 change from projecting distally to projecting radially outward when the distal face 134 displaces proximally towards the proximal face 132.
The following discussion pertains to a delivery method for implanting a leadless pulse generator 120 equipped with a fixation sleeve 130 such as any of those disclosed herein. The method begins with the leadless pulse generator 120 being tracked via delivery tools (e.g., a delivery catheter, etc.) through the patient vasculature to an implantation site in the patient's heart. Upon the distal end of the leadless pulse generator being placed against the implantation site, gentle forward pressure is applied on the delivery catheter until noticing a slight movement of the delivery catheter proximal to the leadless pulse generator and synchronous to the heartbeat. The curve of the catheter down to the inferior vena cava is visualized via fluoroscopy. The implant site and the distal region of the delivery tool(s), plus the leadless pulse generator 120 and its fixation sleeve 130, are visualized via fluoroscopy while the leadless pulse generator 120 is caused to rotate clockwise as the radiopaque marker 124 of the leadless pulse generator is observed, its turns being counted for the appropriate number of turns to cause the helical anchor 66 to screw fully into the cardiac tissue. Simultaneously, the distal face 134 of the radiopaque fixation sleeve 130 and the helical anchor 66 are observed via fluoroscopy, including the positional relationship of the distal face 134 of the sleeve 130 relative to the anchor 66.
While visualizing the radiopaque fixation sleeve during the rotation of the leadless pulse generator 120, if the distal tip electrode 112 remains proximal to the distal face 134 of the fixation sleeve 130, the implanter can safely continue rotating the leadless pulse generator until alignment is observed. Once the helical anchor 66 is adequately imbedded in the cardiac tissue, as can be understood from the relationship of the distal face 134 of the fixation sleeve 130 relative to the distal tip electrode 112 and/or the helical anchor 66, the implanter can uncouple the leadless pulse generator 120 from the delivery tool(s) with confidence that the leadless pulse generator 120 is securely anchored to the engaged cardiac tissue.
As noted above, the fixation sleeve equipped leadless pulse generator 120 disclosed herein is advantageous for a number of reasons. First, the protective sleeve 130 prevents helical anchor engagement or deformation due to inadvertent snagging of cardiac tissue. Second, the compressible sleeve 130 allows fluoroscopic evaluation of distance between cardiac tissue and the distal end electrode 112, thereby conveying information to the implanter regarding whether or not the anchor 66 is properly screwing into cardiac tissue and to what extent. Third, the compressible sleeve 130 provides resistance against over-rotation of the leadless pulse generator during implant. Fourth, the compressible sleeve 130 provides additional contact surface area to reduce contact pressure and mitigate tissue damage. Fifth, the compressible sleeve forms a seal against the endocardium to reduce the possibility of effusion through any potential microperforation created by the helical anchor 66 extending through the thin myocardium. Finally, the compressible sleeve 130 with tines or other radially splaying members 202 can act to prevent anti-rotation of an implanted leadless pulse generator 120.
The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present invention. From the above description and drawings, it will be understood by those of ordinary skill in the art that the particular embodiments shown and described are for purposes of illustrations only and are not intended to limit the scope of the present invention. References to details of particular embodiments are not intended to limit the scope of the invention.
Claims (16)
1. A leadless pulse generator for administering therapy to cardiac tissue, the leadless pulse generator comprising:
a body having a distal end and a proximal end opposite the distal end;
a helical anchor distally extending from the distal end;
an electrode at the distal end; and
a sleeve coupled to the body and distally extending from the distal end of the body, the sleeve comprising a proximal face and a distal face opposite the proximal face, the proximal face adjacent the body, the sleeve coaxially extending about the helical anchor, the sleeve configurable in a biased state wherein the distal face is near a distal tip of the helical anchor, the sleeve configured to compress such that the distal face displaces proximally towards the proximal face upon the distal face being forced against the cardiac tissue in the course of the helical anchor screwing into the cardiac tissue.
2. The leadless pulse generator of claim 1 , further comprising an anchor mount operably coupled to the distal end and supporting the helical anchor, and a portion of the sleeve is sandwiched between the anchor mount and the distal end.
3. The leadless pulse generator of claim 2 , wherein the portion of the sleeve is a radially inward extending annular ring.
4. The leadless pulse generator of claim 2 , wherein the electrode is exposed at a center of the anchor mount.
5. The leadless pulse generator of claim 2 , wherein the anchor mount is threadably operably coupled to the distal end.
6. The leadless pulse generator of claim 1 , wherein the sleeve is radiopaque or comprises a radiopaque portion or component.
7. The leadless pulse generator of claim 1 , wherein the sleeve has a proximal section extending distally from the proximal face and a distal section extending proximally from the distal face, the sleeve configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the distal section folds proximally and the distal face increases in diameter.
8. The leadless pulse generator of claim 7 , wherein, when the sleeve is in the biased state, the distal section has a conical outer shape and the proximal section has a cylindrical outer shape, the conical outer shape distally increasing in diameter.
9. The leadless pulse generator of claim 7 wherein the distal section further comprises a series of longitudinally extending gaps and longitudinally extending members, the members distally terminating as part of the distal face, the gaps and members arranged in a uniformly spaced alternating fashion about a circumference of the distal section.
10. The leadless pulse generator of claim 9 , wherein the members are wider than the gaps.
11. The leadless pulse generator of claim 9 , wherein the gaps are wider than the members.
12. The leadless pulse generator of claim 9 , wherein the members change from projecting distally to projecting radially outward when the distal face displaces proximally towards the proximal face.
13. The leadless pulse generator of claim 1 , wherein the distal face changes from facing distally to facing radially outward when the distal face displaces proximally towards the proximal face.
14. The leadless pulse generator of claim 1 , wherein the sleeve has a proximal cylindrical section extending distally from the proximal face and a distal bellows section extending proximally from the distal face, the distal bellows section having first and second radially outward projecting circumferentially extending ridges and a radially inward projecting circumferentially extending valley located between the first and second ridges.
15. The leadless pulse generator of claim 11 , wherein the sleeve is configured such that, in the course of the helical anchor screwing into the cardiac tissue and the distal face being forced against the cardiac tissue, the first ridge moves proximally towards the second ridge and the valley decreases in dimension distal-proximal.
16. The leadless pulse generator of claim 1 wherein the helical anchor also acts as part of the electrode or is another electrode.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/884,619 US9907953B2 (en) | 2015-10-15 | 2015-10-15 | Fixation sleeve equipped leadless pulse generator |
US15/872,616 US10105536B2 (en) | 2015-10-15 | 2018-01-16 | Fixation sleeve equipped leadless pulse generator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/884,619 US9907953B2 (en) | 2015-10-15 | 2015-10-15 | Fixation sleeve equipped leadless pulse generator |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/872,616 Division US10105536B2 (en) | 2015-10-15 | 2018-01-16 | Fixation sleeve equipped leadless pulse generator |
Publications (2)
Publication Number | Publication Date |
---|---|
US20170106185A1 US20170106185A1 (en) | 2017-04-20 |
US9907953B2 true US9907953B2 (en) | 2018-03-06 |
Family
ID=58522709
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/884,619 Active US9907953B2 (en) | 2015-10-15 | 2015-10-15 | Fixation sleeve equipped leadless pulse generator |
US15/872,616 Active US10105536B2 (en) | 2015-10-15 | 2018-01-16 | Fixation sleeve equipped leadless pulse generator |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/872,616 Active US10105536B2 (en) | 2015-10-15 | 2018-01-16 | Fixation sleeve equipped leadless pulse generator |
Country Status (1)
Country | Link |
---|---|
US (2) | US9907953B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD894396S1 (en) | 2019-03-08 | 2020-08-25 | Pacesetter, Inc. | Leadless biostimulator attachment feature |
US11185704B2 (en) | 2017-11-06 | 2021-11-30 | Pacesetter, Inc. | Biostimulator having fixation element |
US11541243B2 (en) | 2019-03-15 | 2023-01-03 | Pacesetter, Inc. | Biostimulator having coaxial fixation elements |
US11577086B2 (en) | 2018-08-20 | 2023-02-14 | Pacesetter, Inc. | Fixation mechanisms for a leadless cardiac biostimulator |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9308022B2 (en) | 2012-12-10 | 2016-04-12 | Nevro Corporation | Lead insertion devices and associated systems and methods |
US10952678B2 (en) * | 2016-02-09 | 2021-03-23 | Cvdevices, Llc | Devices and systems for tissue engagement and methods of using the same |
US10583286B2 (en) | 2016-08-23 | 2020-03-10 | Boston Scientific Neuromodulation Corporation | Methods and devices for neuromodulation of the adrenal gland |
AU2017316675A1 (en) * | 2016-08-23 | 2018-11-22 | Boston Scientific Neuromodulation Corporation | Leadless Neuromodulation of the Adrenal Gland |
US11198013B2 (en) | 2016-11-21 | 2021-12-14 | Cardiac Pacemakers, Inc. | Catheter and leadless cardiac devices including electrical pathway barrier |
WO2018094193A1 (en) | 2016-11-21 | 2018-05-24 | Cardiac Pacemakers, Inc. | Delivery devices and wall apposition sensing |
US10806931B2 (en) | 2016-12-27 | 2020-10-20 | Cardiac Pacemakers, Inc. | Delivery devices and methods for leadless cardiac devices |
CN110114114B (en) | 2016-12-27 | 2023-05-02 | 心脏起搏器股份公司 | Delivery devices and methods for leadless cardiac devices |
US10485981B2 (en) | 2016-12-27 | 2019-11-26 | Cardiac Pacemakers, Inc. | Fixation methods for leadless cardiac devices |
JP6796727B2 (en) | 2016-12-27 | 2020-12-09 | カーディアック ペースメイカーズ, インコーポレイテッド | Leadless delivery catheter with conduction path |
US10773089B2 (en) | 2017-01-26 | 2020-09-15 | Cardiac Pacemakers, Inc. | Delivery devices and methods for leadless cardiac devices |
US10980999B2 (en) | 2017-03-09 | 2021-04-20 | Nevro Corp. | Paddle leads and delivery tools, and associated systems and methods |
CN110418661B (en) | 2017-03-10 | 2024-01-02 | 心脏起搏器股份公司 | Fixing piece for leadless cardiac device |
US10994148B2 (en) * | 2017-03-20 | 2021-05-04 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US10737092B2 (en) | 2017-03-30 | 2020-08-11 | Cardiac Pacemakers, Inc. | Delivery devices and methods for leadless cardiac devices |
US10905872B2 (en) * | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
NL2019577B1 (en) * | 2017-09-19 | 2019-03-28 | Cardiac Pacemakers Inc | Stimulation/sensing electrode fixation device and electrical lead |
US11577085B2 (en) | 2017-08-03 | 2023-02-14 | Cardiac Pacemakers, Inc. | Delivery devices and methods for leadless cardiac devices |
US11147967B2 (en) * | 2017-10-18 | 2021-10-19 | Boston Scientific Neuromodulation Corporation | Modulation of aldosterone via adrenal gland stimulation |
US11420045B2 (en) | 2018-03-29 | 2022-08-23 | Nevro Corp. | Leads having sidewall openings, and associated systems and methods |
CN108310652B (en) * | 2018-04-10 | 2021-09-28 | 创领心律管理医疗器械(上海)有限公司 | Heart implantation device and pacing system |
CN112020374B (en) | 2018-04-23 | 2024-05-07 | 心脏起搏器股份公司 | Multipolar lead for his bundle pacing |
CN110870948B (en) * | 2018-08-31 | 2021-11-05 | 创领心律管理医疗器械(上海)有限公司 | Delivery device, cardiac pacing device and fixing structure thereof |
FR3086179B1 (en) * | 2018-09-25 | 2020-09-25 | Cairdac | IMPLANTABLE AUTONOMOUS HEART CAPSULE WITH ADJUSTABLE HEAD AND TORQUE LIMITER |
US11517747B2 (en) | 2018-10-16 | 2022-12-06 | Cardiac Pacemakers, Inc. | His lead with extensible electrode and repositioning features |
CN112912131A (en) * | 2018-10-25 | 2021-06-04 | 先导者股份有限公司 | Biostimulator feedthrough with integral electrode cup |
USD893730S1 (en) * | 2019-03-20 | 2020-08-18 | Pacesetter, Inc. | Biostimulator loading tool |
EP3946556B1 (en) | 2019-03-29 | 2024-06-19 | Cardiac Pacemakers, Inc. | Systems for treating cardiac arrhythmias |
EP3946568A1 (en) | 2019-03-29 | 2022-02-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US11684776B2 (en) * | 2019-08-13 | 2023-06-27 | Medtronic, Inc. | Fixation component for multi-electrode implantable medical device |
US11571582B2 (en) | 2019-09-11 | 2023-02-07 | Cardiac Pacemakers, Inc. | Tools and systems for implanting and/or retrieving a leadless cardiac pacing device with helix fixation |
US11510697B2 (en) | 2019-09-11 | 2022-11-29 | Cardiac Pacemakers, Inc. | Tools and systems for implanting and/or retrieving a leadless cardiac pacing device with helix fixation |
WO2021083792A1 (en) * | 2019-11-01 | 2021-05-06 | Biotronik Se & Co. Kg | Implantable medical device comprising an anchoring device |
US11389647B2 (en) | 2020-02-03 | 2022-07-19 | Nevro Corp. | Neurological stimulation lead anchors and associated tools, and methods |
JP2024512889A (en) * | 2021-04-09 | 2024-03-21 | バイオトロニック エスエー アンド カンパニー カーゲー | Method for manufacturing implantable intracardiac devices and header assemblies |
US20240316347A1 (en) * | 2023-03-21 | 2024-09-26 | Pacesetter, Inc. | Biostimulator having movable pacing element |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070050003A1 (en) | 2005-08-30 | 2007-03-01 | Cardiac Pacemakers, Inc. | Device on lead to prevent perforation and/or fixate lead |
US20070088397A1 (en) | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Leadless cardiac pacemaker system with conductive communication |
US20100222860A1 (en) | 2009-03-02 | 2010-09-02 | Pacesetter, Inc. | Implantable Leads Having Mechanisms to Impede Over-Rotation of Fixation Mechanisms |
US20100222855A1 (en) | 2007-05-15 | 2010-09-02 | Rolf Hill | MEDICAL IMPLANTABLE LEAD WITH FLEXIBLE SEGMENTED SLEEVE (As Amended) |
US7801624B1 (en) | 2007-01-16 | 2010-09-21 | Pacesetter, Inc. | Reduced perforation distal tip for an implantable cardiac electrotherapy lead |
US9216285B1 (en) * | 2014-12-18 | 2015-12-22 | Pacesetter, Inc. | Leadless implantable medical device having removable and fixed components |
US20160096001A1 (en) * | 2014-10-07 | 2016-04-07 | Pacesetter, Inc. | Delivery catheter systems and methods |
-
2015
- 2015-10-15 US US14/884,619 patent/US9907953B2/en active Active
-
2018
- 2018-01-16 US US15/872,616 patent/US10105536B2/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070050003A1 (en) | 2005-08-30 | 2007-03-01 | Cardiac Pacemakers, Inc. | Device on lead to prevent perforation and/or fixate lead |
US8010209B2 (en) | 2005-10-14 | 2011-08-30 | Nanostim, Inc. | Delivery system for implantable biostimulator |
US20070088396A1 (en) | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Leadless cardiac pacemaker |
WO2007047681A2 (en) | 2005-10-14 | 2007-04-26 | Nanostim, Inc. | Leadless cardiac pacemaker and system |
US7937148B2 (en) | 2005-10-14 | 2011-05-03 | Nanostim, Inc. | Rate responsive leadless cardiac pacemaker |
US7945333B2 (en) | 2005-10-14 | 2011-05-17 | Nanostim, Inc. | Programmer for biostimulator system |
US20070088397A1 (en) | 2005-10-14 | 2007-04-19 | Jacobson Peter M | Leadless cardiac pacemaker system with conductive communication |
US8352025B2 (en) | 2005-10-14 | 2013-01-08 | Nanostim, Inc. | Leadless cardiac pacemaker triggered by conductive communication |
US8457742B2 (en) | 2005-10-14 | 2013-06-04 | Nanostim, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
US7801624B1 (en) | 2007-01-16 | 2010-09-21 | Pacesetter, Inc. | Reduced perforation distal tip for an implantable cardiac electrotherapy lead |
US20100222855A1 (en) | 2007-05-15 | 2010-09-02 | Rolf Hill | MEDICAL IMPLANTABLE LEAD WITH FLEXIBLE SEGMENTED SLEEVE (As Amended) |
US20100222860A1 (en) | 2009-03-02 | 2010-09-02 | Pacesetter, Inc. | Implantable Leads Having Mechanisms to Impede Over-Rotation of Fixation Mechanisms |
US20160096001A1 (en) * | 2014-10-07 | 2016-04-07 | Pacesetter, Inc. | Delivery catheter systems and methods |
US9216285B1 (en) * | 2014-12-18 | 2015-12-22 | Pacesetter, Inc. | Leadless implantable medical device having removable and fixed components |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11185704B2 (en) | 2017-11-06 | 2021-11-30 | Pacesetter, Inc. | Biostimulator having fixation element |
US11850435B2 (en) | 2017-11-06 | 2023-12-26 | Pacesetter, Inc. | Biostimulator having fixation element |
US11577086B2 (en) | 2018-08-20 | 2023-02-14 | Pacesetter, Inc. | Fixation mechanisms for a leadless cardiac biostimulator |
USD894396S1 (en) | 2019-03-08 | 2020-08-25 | Pacesetter, Inc. | Leadless biostimulator attachment feature |
US11541243B2 (en) | 2019-03-15 | 2023-01-03 | Pacesetter, Inc. | Biostimulator having coaxial fixation elements |
Also Published As
Publication number | Publication date |
---|---|
US20170106185A1 (en) | 2017-04-20 |
US10105536B2 (en) | 2018-10-23 |
US20180133465A1 (en) | 2018-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10105536B2 (en) | Fixation sleeve equipped leadless pulse generator | |
CN108883267B (en) | Interventional medical device, device system and fixing assembly thereof | |
US9526891B2 (en) | Intracardiac medical device | |
EP3448490B1 (en) | Interventional medical systems and associated assemblies | |
US8738152B2 (en) | Lead assembly including a polymer interconnect and methods related thereto | |
US8219213B2 (en) | Active fixation cardiac vein medical lead | |
US8170691B2 (en) | Medical implantable lead | |
WO2014176076A1 (en) | Electrode assemblies and associated fixation members for implantable medical devices | |
CN112714662B (en) | Hill bundle conductor with extendable electrode and repositioning feature | |
EP1409071A2 (en) | Implantable coronary sinus lead | |
US9192317B2 (en) | Implantable active fixation lead with biodegradable helical tip | |
US20140243946A1 (en) | Implantable medical device including assembly incorporating radiopaque agent and elutable drug into a polymeric lead tip | |
US8346374B2 (en) | Laminate distal lead seal with tissue ingrowth feature | |
US8543224B2 (en) | Active fixation lead with helix securement mechanism | |
US8160721B2 (en) | Implantable lead with flexible tip features | |
JP5688469B2 (en) | Implantable medical electrical lead | |
EP4434574A1 (en) | Biostimulator having movable pacing element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: PACESETTER, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ORTS, SONDRA;BOLING, CARL LANCE;FISHLER, MATTHEW G.;AND OTHERS;SIGNING DATES FROM 20151014 TO 20151015;REEL/FRAME:036805/0050 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |